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a b s t r a c t
The synthesis of a functionalized 1-oxo-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid has been per-
formed in 10 steps from the readily available dimedone. Only three puriﬁcations by ﬂash chromatogra-
phy are required through the whole sequence. The key step is the reaction between a dimedone
derivative and a chlorotetrolic ester, that gives a tetrasubstituted benzene ring (through a Diels–Alder/
retro- Diels–Alder process) bearing the substituents in the suitable positions for further functionalization.
 2012 Elsevier Ltd. All rights reserved.
The 1-oxo-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid
structure, such as 1, is related to inhibitors of WNV protease1 and
tomolecules having selective central nervous system (CNS) action.2
Additionally, 1-oxo-1,2,3,4-tetrahydroisoquinoline-3-carboxylic
acids can also be used in the synthesis of 1,2,3,4-tetrahydroisoquin-
oline-3-carboxylic acids,3 which are constrained analogues of phen-
ylalanine with several pharmacologically relevant properties.4 As
part of our ongoing research program directed toward the synthesis
of biologically active molecules,5 1-oxo-1,2,3,4-tetrahydroisoquin-
oline-3-carboxylic acid 1 was designed as an important target.
Our initial strategy to obtain the required functionalized 1-oxo-
1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid 1 was based on
the manipulation of the tetrasubstituted benzene 2, which could
be obtained by a Diels–Alder reaction of Brassard’s diene (3)6 and
chlorotetrolic ester (4) followed by aromatization (Scheme 1).
The chlorotetrolic ester 4 was prepared from propargyl chloride
(5)7 and the Brassard’s diene (3) was obtained from methyl aceto-
acetate (Scheme 2).8
The cycloaddition of Brassard’s diene (3) and 4was investigated
under several conditions, including the presence of Lewis acids,
such as ZnCl2 and AlCl3. Table 1 summarizes the most important
reactions. The best result was the isolation of 2 and 6, in 25% and
20% yields, respectively, when the two components were heated
to 80 C without solvent (entry 3). Increasing the temperature,
decomposition was observed (entry 4), whereas no reaction was
observed at lower temperature (entries 1 and 2).
Considering the results using the Brassard’s diene, we tuned our
attention to the use of the more reactive diene 8, whose ﬁxed s-cis
conﬁguration could favor the Diels–Alder cycloaddition. The diene
8was obtained from dimedone (7) by two different ways. The syn-
thesis of 8 is feasible in one step from 7. However, 2.2 equiv of
TMSOTf should be used and the puriﬁcationof crude8 bydistillation
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Scheme 2. Preparation of Brassard’s diene 3 and chloro-tetrolic ester 4.
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is mandatory to remove the excess of TMSOTf. To avoid these draw-
backs, the two-step preparationwas chosen for large scale reactions
because the crude product was obtained pure enough to be used in
the next step without any puriﬁcation (Scheme 3).9
The reaction between the diene 8 and the alkyne 4 gave the de-
sired aromatic compound 9 in 72% yield. Decreasing the excess of 8
to 2 equiv, compound 9 was obtained in 26% yield (Scheme 4).
The substituted benzene 9 is formed through a sequence of
reactions.10 First, a Diels–Alder reaction produces the bicyclic com-
pound 10, that undergoes a retro- Diels–Alder reaction furnishing
isobutylene and 11. After hydrolysis of the TMS groups during
work-up, 9 is isolated (Scheme 5).
The two phenolic groups of 9 can be chemically distinguished
because the phenol ortho to the ester is involved in an intramolec-
ular hydrogen bonding, resulting in a higher pKa value.11 Thus, the
next step was the selective methylation of the more acidic phenol
group using dimethylsulfate, yielding 2, after recrystallization. The
remaining phenol group was then tosylated using TsCl, affording
12a. The protection of the phenol 2 was also performed with TBS
and TIPS, leading to 12b/c, respectively (Scheme 6).
The alkyl chain was introduced via the substitution of the chlo-
rine of 12a by the anion of diethyl malonate, forming the triester
13a, in 68% yield. When this transformation was performed with
12b,c, the unprotected coupling product 13d was obtained in only
35% and 24% yields, respectively. Using NaH as a base to remove
the a-carbonyl hydrogen of the malonate moiety of 13a, and NBS
as a bromine source, compound 14 was prepared in 97% yield
(Scheme 7).
The azide 15 was formed after nucleophilic substitution of the
bromine of 14 by an azide, using NaN3 in DMF. Reduction of the
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Scheme 4. Synthesis of 9 through Diels–Alder/retro-Diels–Alder.
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Scheme 5. Mechanism for the Formation of 9 through Diels–Alder/retro-Diels–
Alder.
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Scheme 9. Final step toward the target acid 1.
Table 1
Reaction of Brassard’s diene (3) with 4
3 + 4
OH
MeO
CO2Et
Cl
2
+ Cl
MeO
MeO2C CO2Et
6
Entry Conditions Product (isolated yield)
1 Neat, rt No reaction
2 Neat, 50 C No reaction
3 Neat, 80 C, 45 h 2 (25%), 6 (20%)
4 Neat, 100 C, 45 h Decomposition
5 THF or toluene, 80 C No reaction
6 Neat, ZnCl2 or AlCl3 (10 mol %), rt No reaction
7 Neat, 1 equiv AlCl3, rt Decomposition
8 Toluene or benzene, 0.5 equiv AlCl3, 80 C 2 (13%)
9 Toluene, 1 equiv AlCl3, 80 C 2 (15%)
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azide group of 15 using 10% wt Pd/C in MeOH, under 2 atm of H2
produced the amine 16 in 43%, together with 13a, in 28% yield,
which is formed from a hydrogenolysis (Scheme 8). The triester
13a was recycled in the synthetic route. Using Pd/CaCO3 as cata-
lyst, only hydrogenolysis was observed.
When 16 was subjected to a basic hydrolysis using LiOH fol-
lowed by a reﬂux in diluted acid to promote decarboxylation, the
tetrahydroisoquinoline 1 was produced in 77% yield (Scheme 9).
In conclusion, a new and practical route to obtain a functional-
ized 1-oxo-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid was
developed from the readily available dimedone. The synthesis is
ten step long and only three puriﬁcations by ﬂash chromatography
are required through the whole sequence (see Supplementary data
for details). The key step is the reaction between the dimedone
derivative 8 and the chlorotetrolic ester 4, that gives a tetrasubsti-
tuted benzene through a Diels–Alder /retro- Diels–Alder process.
The sequence can be easily adapted to the synthesis of other 1-
oxo-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acids.
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